Edap TMS SA (FRA:EDA)

Q2 2026 Edap Tms SA Earnings Call Transcript

Aug 13, 2026 / 08:30 PM GMT

Release Date Price: €4.08 (-7.69%)

Transcript 10-Q8-K8-K

Key Points

Positve

HIFU revenue grew 39% year-over-year to $13.2 million in Q2 2026, with 13 Focal One capital system sales, a 44% increase.
U.S. Focal 1 procedure volumes increased 47% year-over-year, demonstrating strong recurring revenue growth.
Gross margin improved to 55.6% from 51.1% in the prior year, driven by lower system costs and disciplined pricing.
CMS proposed a 12% increase in HIFU facility payment for 2027, marking the fifth consecutive annual increase, supporting reimbursement predictability.
Expansion into new indications (BPH and endometriosis) is progressing, with 14 BPH patients treated and the first commercial endometriosis program launched in Europe.
The company raised $40 million in an equity offering, strengthening its balance sheet to fund growth initiatives.
The install base grew to 184 systems, with 15 U.S. hospital networks owning two or more systems, including repeat placements at Cleveland Clinic and Kaiser Permanente.

Negative

Operating expenses increased to $15.4 million from $11.5 million, driven by higher investment in growth initiatives.
Net loss widened due to a $6.3 million non-cash charge from changes in fair value of EIB warrants and interest expense.
Shareholders' equity was negative $3.2 million at quarter-end, though the recent equity raise is expected to improve it.
Discontinued operations (ESWL and distribution) saw a 34% revenue decline, reflecting ongoing termination of distribution agreements.
The company faces foreign exchange headwinds, with a $400,000 unfavorable impact in the quarter.
Tariff impacts totaled approximately $500,000 on the quarter's results.
BPH and endometriosis contributions to revenue are expected to be minimal in the near term, with material impact not anticipated until 2027.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FOCL.OQ - Edap Tms SA
Q2 2026 Edap Tms SA Earnings Call
Aug 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Please stand by, your meeting is about to begin.

Good afternoon, everyone. Welcome to today's Focal Theryx second quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, you will have the opportunity to ask questions during the question-and-answer session. To register to ask a question at any time, please press 1 on your telephone. If you would like to remove yourself from the queue, press 2. And please note today's call is being recorded. It is now my pleasure to turn the meeting over to Ms. Louisa Smith from Gilmartin Group. Please go ahead, ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.